Diclofenac Epolamine System
Product Images NDC 82347-0405

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Diclofenac Epolamine (NDC 82347-0405). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Yaral Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Diclofenac 01)

Chemical structure diagram of Diclofenac Epolamine. The image shows the molecular structures of diclofenac and epolamine, including the chlorinated aromatic rings of diclofenac and the 2-(pyrrolidin-1-yl)ethanol structure of epolamine.*

FDA Label Image

Figure 1 (Diclofenac 02)

A line chart comparing the percentage of patients improved versus percent improvement from baseline for Diclofenac Patch and placebo. The vertical axis represents percent of patients improved, and the horizontal axis shows percent improvement from baseline, illustrating higher improvement rates for the Diclofenac Patch compared to placebo across the measurement range.*

FDA Label Image

Figure 2 (Diclofenac 03)

A line graph comparing the percent improvement from baseline with the percent of patients improved for Diclofenac Patch versus Placebo. The y-axis shows percent of patients improved, and the x-axis shows percent improvement from baseline. Two lines represent Diclofenac Patch (higher improvement) and Placebo.*

FDA Label Image

Figure 3 (Diclofenac 04)

A comparative line graph showing the percent of patients improved versus percent improvement from baseline for Diclofenac Patch and placebo. The graph shows two data series with percent improvement on the x-axis and percent of patients improved on the y-axis, illustrating higher patient improvement with Diclofenac Patch compared to placebo.*

FDA Label Image

Figure 4 (Diclofenac 05)

A line graph comparing the percent of patients improved versus percent improvement from baseline for Diclofenac Patch and placebo. The graph shows two lines, one for Diclofenac Patch and one for placebo, illustrating differences in patient improvement rates across varying levels of improvement from baseline.*

FDA Label Image

Principal Display Panel (30 Topical System Pouch Carton)

The packaging label for Diclofenac Epolamine topical system 1.3% by YARAL Pharma Inc. is shown. It is a prescription topical system with 30 units, each measuring 10 cm by 14 cm. The label includes directions for use, storage, warnings, and instructions on application and disposal. The product is made in Italy and distributed by YARAL Pharma, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.